Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.57 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.54 |
| ▸ | THRA | P10827 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.51 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.48 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2352668 | 1.00 | TSHR (0.65) | TSHRSMPD1PLA2G4BTHRATHRB | |
| SCHEMBL25169961 | 1.00 | TSHR (0.65) | TSHRSMPD1PLA2G4BTHRATHRB | |
| SCHEMBL25167623 | 1.00 | TSHR (0.65) | TSHRSMPD1PLA2G4BTHRATHRB | |
| SCHEMBL4187873 | 0.93 | TSHR (0.54) | TSHRSMPD1PLA2G4BTHRBLTA4H | |
| SCHEMBL8552100 | 0.87 | KMT2A (0.59) | TSHRSMPD1KMT2ANR1H4GPBAR1 | |
| SCHEMBL6677146 | 0.87 | TSHR (0.76) | TSHRSMPD1PLA2G4BTHRATHRB | |
| SCHEMBL17138169 | 0.87 | TSHR (0.76) | TSHRSMPD1PLA2G4BTHRATHRB | |
| SCHEMBL4208924 | 0.87 | TSHR (0.76) | TSHRSMPD1PLA2G4BTHRATHRB | |
| SCHEMBL3905859 | 0.87 | TSHR (0.76) | TSHRSMPD1PLA2G4BTHRATHRB | |
| SCHEMBL16699620 | 0.87 | TSHR (0.76) | TSHRSMPD1PLA2G4BTHRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353867-A1 | Substituted Pyridine-2,6-Bis(Phenylenephenolate) Complexes with Enhanced Solubility that are Useful as Catalyst Components for Olefin Polymerization | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2025-11-20 | — | — | US | disclosed |
| EP-4519332-A1 | SUBSTITUTED PYRIDINE-2,6-BIS (PHENYLENEPHENOLATE) COMPLEXES WITH ENHANCED SOLUBILITY THAT ARE USEFUL AS CATALYST COMPONENTS FOR OLEFIN POLYMERIZATION | ExxonMobil Chemical Patents Inc. (US) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023215695-A1 | SUBSTITUTED PYRIDINE-2,6-BIS (PHENYLENEPHENOLATE) COMPLEXES WITH ENHANCED SOLUBILITY THAT ARE USEFUL AS CATALYST COMPONENTS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353867-A1 | Substituted Pyridine-2,6-Bis(Phenylenephenolate) Complexes with Enhanced Solubility that are Useful as Catalyst Components for Olefin Polymerization | HPD, YAP1, PAH | TSHR 4771/4885SMPD1 4784/4885PLA2G4B 2074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.